Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS

Steven W. Blue, Andrea J. Winchell, Amy V. Kaucher, Rachel A. Lieberman, Christopher T. Gilles, Maria N. Pyra, Renee Heffron, Xuanlin Hou, Robert W. Coombs, Kavita Nanda, Nicole L. Davis, Athena P. Kourtis, Joshua T. Herbeck, Jared M. Baeten, Jairam R. Lingappa, David Erikson

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: The objective was to develop a method to simultaneously quantify five commonly used hormonal contraceptives (HCs) and two endogenous sex steroids by liquid chromatography–tandem triple quadrupole mass spectrometry (LC–MS/MS) and apply this method to human serum samples. Study design: We developed a method to simultaneously analyze ethinyl estradiol (EE2), etonogestrel (ENG), levonorgestrel (LNG), medroxyprogesterone acetate (MPA) and norethisterone (NET), along with estradiol (E2) and progesterone (P4), in human serum for a Shimadzu Nexera-LCMS-8050 LC–MS/MS platform. We analyzed serum collected from women self-reporting use of oral contraceptives, contraceptive implants or injectable contraceptives (n=14) and normally cycling women using no HC (n=15) as well as pooled samples from women administered various HCs (ENG, n=6; LNG, n=14; MPA, n=7; NET, n=5). Results: Limits of quantitation were 0.010 ng/mL for E2, EE2 and P4; 0.020 ng/mL for ENG, LNG and MPA; and 0.040 ng/mL for NET. Precisions for all assays, as indicated by coefficient of variation, were less than or equal to 12.1%. Accuracies for all assays were in the range of 95%–108%. Endogenous hormone values obtained from analysis of human serum samples are in agreement with levels previously reported in the literature for normally cycling women as well as for women taking the appropriate HC. Conclusions: We have developed a robust, accurate and sensitive method for simultaneously analyzing commonly used contraceptive steroids and endogenous sex steroids in human serum. Implications: This analytical method can be used for quantitating contraceptive steroid levels in women for monitoring systemic exposure to determine drug interactions, nonadherence, misreporting and proper dosing.

Original languageEnglish (US)
Pages (from-to)363-369
Number of pages7
JournalContraception
Volume97
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Contraceptive Agents
Hormones
Serum
Norethindrone
Levonorgestrel
Medroxyprogesterone Acetate
Steroids
Ethinyl Estradiol
Oral Contraceptives
Drug Interactions
Progesterone
Estradiol
Mass Spectrometry
Injections
etonogestrel

Keywords

  • Hormonal contraceptive
  • LC–MS/MS
  • Liquid chromatography
  • Mass spectrometry
  • Steroid

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Blue, S. W., Winchell, A. J., Kaucher, A. V., Lieberman, R. A., Gilles, C. T., Pyra, M. N., ... Erikson, D. (2018). Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS. Contraception, 97(4), 363-369. https://doi.org/10.1016/j.contraception.2018.01.015

Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS. / Blue, Steven W.; Winchell, Andrea J.; Kaucher, Amy V.; Lieberman, Rachel A.; Gilles, Christopher T.; Pyra, Maria N.; Heffron, Renee; Hou, Xuanlin; Coombs, Robert W.; Nanda, Kavita; Davis, Nicole L.; Kourtis, Athena P.; Herbeck, Joshua T.; Baeten, Jared M.; Lingappa, Jairam R.; Erikson, David.

In: Contraception, Vol. 97, No. 4, 01.04.2018, p. 363-369.

Research output: Contribution to journalArticle

Blue, SW, Winchell, AJ, Kaucher, AV, Lieberman, RA, Gilles, CT, Pyra, MN, Heffron, R, Hou, X, Coombs, RW, Nanda, K, Davis, NL, Kourtis, AP, Herbeck, JT, Baeten, JM, Lingappa, JR & Erikson, D 2018, 'Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS', Contraception, vol. 97, no. 4, pp. 363-369. https://doi.org/10.1016/j.contraception.2018.01.015
Blue SW, Winchell AJ, Kaucher AV, Lieberman RA, Gilles CT, Pyra MN et al. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS. Contraception. 2018 Apr 1;97(4):363-369. https://doi.org/10.1016/j.contraception.2018.01.015
Blue, Steven W. ; Winchell, Andrea J. ; Kaucher, Amy V. ; Lieberman, Rachel A. ; Gilles, Christopher T. ; Pyra, Maria N. ; Heffron, Renee ; Hou, Xuanlin ; Coombs, Robert W. ; Nanda, Kavita ; Davis, Nicole L. ; Kourtis, Athena P. ; Herbeck, Joshua T. ; Baeten, Jared M. ; Lingappa, Jairam R. ; Erikson, David. / Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS. In: Contraception. 2018 ; Vol. 97, No. 4. pp. 363-369.
@article{84a4dba5975348c7bc98f6682627c9a8,
title = "Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS",
abstract = "Objective: The objective was to develop a method to simultaneously quantify five commonly used hormonal contraceptives (HCs) and two endogenous sex steroids by liquid chromatography–tandem triple quadrupole mass spectrometry (LC–MS/MS) and apply this method to human serum samples. Study design: We developed a method to simultaneously analyze ethinyl estradiol (EE2), etonogestrel (ENG), levonorgestrel (LNG), medroxyprogesterone acetate (MPA) and norethisterone (NET), along with estradiol (E2) and progesterone (P4), in human serum for a Shimadzu Nexera-LCMS-8050 LC–MS/MS platform. We analyzed serum collected from women self-reporting use of oral contraceptives, contraceptive implants or injectable contraceptives (n=14) and normally cycling women using no HC (n=15) as well as pooled samples from women administered various HCs (ENG, n=6; LNG, n=14; MPA, n=7; NET, n=5). Results: Limits of quantitation were 0.010 ng/mL for E2, EE2 and P4; 0.020 ng/mL for ENG, LNG and MPA; and 0.040 ng/mL for NET. Precisions for all assays, as indicated by coefficient of variation, were less than or equal to 12.1{\%}. Accuracies for all assays were in the range of 95{\%}–108{\%}. Endogenous hormone values obtained from analysis of human serum samples are in agreement with levels previously reported in the literature for normally cycling women as well as for women taking the appropriate HC. Conclusions: We have developed a robust, accurate and sensitive method for simultaneously analyzing commonly used contraceptive steroids and endogenous sex steroids in human serum. Implications: This analytical method can be used for quantitating contraceptive steroid levels in women for monitoring systemic exposure to determine drug interactions, nonadherence, misreporting and proper dosing.",
keywords = "Hormonal contraceptive, LC–MS/MS, Liquid chromatography, Mass spectrometry, Steroid",
author = "Blue, {Steven W.} and Winchell, {Andrea J.} and Kaucher, {Amy V.} and Lieberman, {Rachel A.} and Gilles, {Christopher T.} and Pyra, {Maria N.} and Renee Heffron and Xuanlin Hou and Coombs, {Robert W.} and Kavita Nanda and Davis, {Nicole L.} and Kourtis, {Athena P.} and Herbeck, {Joshua T.} and Baeten, {Jared M.} and Lingappa, {Jairam R.} and David Erikson",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.contraception.2018.01.015",
language = "English (US)",
volume = "97",
pages = "363--369",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS

AU - Blue, Steven W.

AU - Winchell, Andrea J.

AU - Kaucher, Amy V.

AU - Lieberman, Rachel A.

AU - Gilles, Christopher T.

AU - Pyra, Maria N.

AU - Heffron, Renee

AU - Hou, Xuanlin

AU - Coombs, Robert W.

AU - Nanda, Kavita

AU - Davis, Nicole L.

AU - Kourtis, Athena P.

AU - Herbeck, Joshua T.

AU - Baeten, Jared M.

AU - Lingappa, Jairam R.

AU - Erikson, David

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Objective: The objective was to develop a method to simultaneously quantify five commonly used hormonal contraceptives (HCs) and two endogenous sex steroids by liquid chromatography–tandem triple quadrupole mass spectrometry (LC–MS/MS) and apply this method to human serum samples. Study design: We developed a method to simultaneously analyze ethinyl estradiol (EE2), etonogestrel (ENG), levonorgestrel (LNG), medroxyprogesterone acetate (MPA) and norethisterone (NET), along with estradiol (E2) and progesterone (P4), in human serum for a Shimadzu Nexera-LCMS-8050 LC–MS/MS platform. We analyzed serum collected from women self-reporting use of oral contraceptives, contraceptive implants or injectable contraceptives (n=14) and normally cycling women using no HC (n=15) as well as pooled samples from women administered various HCs (ENG, n=6; LNG, n=14; MPA, n=7; NET, n=5). Results: Limits of quantitation were 0.010 ng/mL for E2, EE2 and P4; 0.020 ng/mL for ENG, LNG and MPA; and 0.040 ng/mL for NET. Precisions for all assays, as indicated by coefficient of variation, were less than or equal to 12.1%. Accuracies for all assays were in the range of 95%–108%. Endogenous hormone values obtained from analysis of human serum samples are in agreement with levels previously reported in the literature for normally cycling women as well as for women taking the appropriate HC. Conclusions: We have developed a robust, accurate and sensitive method for simultaneously analyzing commonly used contraceptive steroids and endogenous sex steroids in human serum. Implications: This analytical method can be used for quantitating contraceptive steroid levels in women for monitoring systemic exposure to determine drug interactions, nonadherence, misreporting and proper dosing.

AB - Objective: The objective was to develop a method to simultaneously quantify five commonly used hormonal contraceptives (HCs) and two endogenous sex steroids by liquid chromatography–tandem triple quadrupole mass spectrometry (LC–MS/MS) and apply this method to human serum samples. Study design: We developed a method to simultaneously analyze ethinyl estradiol (EE2), etonogestrel (ENG), levonorgestrel (LNG), medroxyprogesterone acetate (MPA) and norethisterone (NET), along with estradiol (E2) and progesterone (P4), in human serum for a Shimadzu Nexera-LCMS-8050 LC–MS/MS platform. We analyzed serum collected from women self-reporting use of oral contraceptives, contraceptive implants or injectable contraceptives (n=14) and normally cycling women using no HC (n=15) as well as pooled samples from women administered various HCs (ENG, n=6; LNG, n=14; MPA, n=7; NET, n=5). Results: Limits of quantitation were 0.010 ng/mL for E2, EE2 and P4; 0.020 ng/mL for ENG, LNG and MPA; and 0.040 ng/mL for NET. Precisions for all assays, as indicated by coefficient of variation, were less than or equal to 12.1%. Accuracies for all assays were in the range of 95%–108%. Endogenous hormone values obtained from analysis of human serum samples are in agreement with levels previously reported in the literature for normally cycling women as well as for women taking the appropriate HC. Conclusions: We have developed a robust, accurate and sensitive method for simultaneously analyzing commonly used contraceptive steroids and endogenous sex steroids in human serum. Implications: This analytical method can be used for quantitating contraceptive steroid levels in women for monitoring systemic exposure to determine drug interactions, nonadherence, misreporting and proper dosing.

KW - Hormonal contraceptive

KW - LC–MS/MS

KW - Liquid chromatography

KW - Mass spectrometry

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=85042143140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042143140&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2018.01.015

DO - 10.1016/j.contraception.2018.01.015

M3 - Article

VL - 97

SP - 363

EP - 369

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 4

ER -